DAWN
Price
$10.50
Change
-$0.23 (-2.14%)
Updated
Jan 15 closing price
Capitalization
1.08B
52 days until earnings call
Intraday BUY SELL Signals
XNCR
Price
$13.21
Change
-$1.24 (-8.58%)
Updated
Jan 15 closing price
Capitalization
943.33M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DAWN vs XNCR

Header iconDAWN vs XNCR Comparison
Open Charts DAWN vs XNCRBanner chart's image
Day One Biopharmaceuticals
Price$10.50
Change-$0.23 (-2.14%)
Volume$3.23M
Capitalization1.08B
Xencor
Price$13.21
Change-$1.24 (-8.58%)
Volume$514.9K
Capitalization943.33M
DAWN vs XNCR Comparison Chart in %
View a ticker or compare two or three
VS
DAWN vs. XNCR commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (DAWN: $10.50 vs. XNCR: $13.21)
Brand notoriety: DAWN and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 119% vs. XNCR: 66%
Market capitalization -- DAWN: $1.08B vs. XNCR: $943.33M
DAWN [@Biotechnology] is valued at $1.08B. XNCR’s [@Biotechnology] market capitalization is $943.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, DAWN is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • DAWN’s TA Score: 5 bullish, 4 bearish.
  • XNCR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than XNCR.

Price Growth

DAWN (@Biotechnology) experienced а +13.51% price change this week, while XNCR (@Biotechnology) price change was -6.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Reported Earning Dates

DAWN is expected to report earnings on Mar 09, 2026.

XNCR is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DAWN($1.08B) has a higher market cap than XNCR($943M). DAWN YTD gains are higher at: 12.661 vs. XNCR (-13.717). XNCR has higher annual earnings (EBITDA): -85.79M vs. DAWN (-162.07M). XNCR (471M) and DAWN (452M) have equal amount of cash in the bank . DAWN has less debt than XNCR: DAWN (2.89M) vs XNCR (69.3M). XNCR has higher revenues than DAWN: XNCR (150M) vs DAWN (134M).
DAWNXNCRDAWN / XNCR
Capitalization1.08B943M114%
EBITDA-162.07M-85.79M189%
Gain YTD12.661-13.717-92%
P/E RatioN/AN/A-
Revenue134M150M89%
Total Cash452M471M96%
Total Debt2.89M69.3M4%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNXNCR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 5 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
64%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
DAWN
Daily Signal:
Gain/Loss:
XNCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZSCIX36.850.70
+1.94%
Zacks Small-Cap Core Institutional
NBGIX58.080.85
+1.49%
Neuberger Genesis Instl
LMASX35.150.21
+0.60%
ClearBridge Small Cap C
NBMTX15.470.06
+0.39%
Neuberger Mid Cap Growth Tr
PQIPX14.68N/A
N/A
PIMCO Dividend and Income I2

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-2.14%
BEAM - DAWN
46%
Loosely correlated
-9.49%
VCYT - DAWN
43%
Loosely correlated
-3.42%
FHTX - DAWN
43%
Loosely correlated
-0.48%
XNCR - DAWN
42%
Loosely correlated
-8.58%
REPL - DAWN
42%
Loosely correlated
-5.32%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with NUVL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-8.58%
NUVL - XNCR
60%
Loosely correlated
-1.56%
KURA - XNCR
59%
Loosely correlated
-4.81%
CRNX - XNCR
59%
Loosely correlated
+1.82%
IDYA - XNCR
58%
Loosely correlated
-2.62%
SYRE - XNCR
57%
Loosely correlated
-0.21%
More